Effect of cinromide on inhibitory and excitatory mechanismsFROMM, G. H; TERRENCE, C. F; CHATTHA, A. S et al.Epilepsia (Copenhagen). 1983, Vol 24, Num 4, pp 394-400, issn 0013-9580Article

Cinromide in epilepsy: a pilot studyWILENSKY, A. J; OJEMANN, L. M; FRIEL, P. N et al.Epilepsia (Copenhagen). 1983, Vol 24, Num 4, pp 401-409, issn 0013-9580Article

Cinromide in the treatment of absence seizuresCORWIN, H. M; DREIFUSS, F. E.Epilepsia (Copenhagen). 1983, Vol 24, Num 4, pp 427-430, issn 0013-9580Article

A double-blind crossover study of cinromide versus placebo in epileptic outpatients with partial seizuresSPILKER, B; BRUNI, J; JONES, M et al.Epilepsia (Copenhagen). 1983, Vol 24, Num 4, pp 410-421, issn 0013-9580Article

PREDICTION OF STEADY-STATE BEHAVIOR OF METABOLITE FROM DOSING OF PARENT DRUGLANE EA; LEVY RH.1980; J. PHARM. SCI.; USA; DA. 1980; VOL. 69; NO 5; PP. 610-612; BIBL. 7 REF.Article

A controlled trial of cinromideALLEN, J. W; HAMILTON, M. J; OXLEY, J et al.Epilepsia (Copenhagen). 1983, Vol 24, Num 4, pp 422-426, issn 0013-9580Article

Fractions metabolized in a triangular metabolic system: cinromide and two metabolites in the rhesus monkeyLANE, E. A; LEVY, R. H.Journal of pharmacokinetics and biopharmaceutics. 1985, Vol 13, Num 4, pp 373-386, issn 0090-466XArticle

QUANTITATION OF THE ANTICONVULSANT CINROMIDE (3-BROMO-N-ETHYLCINNAMIDE) AND ITS MAJOR PLASMA METABOLITES BY THIN-LAYER CHROMATOGRAPHYDEANGELIS RL; ROBINSON MM; BROWN AR et al.1980; J. CHROMATOGR.; ISSN 0021-9673; NLD; DA. 1980; VOL. 221; NO 2; PP. 353-360; BIBL. 9 REF.Article

Double-blind, placebo-controlled evaluation of cinromide in patients with the Lennox-Gastaut syndromeEpilepsia (Copenhagen). 1989, Vol 30, Num 4, pp 422-429, issn 0013-9580Article